IMPORTANT INFORMATION - PLEASE READ
The Henslow research you are about to view has been specifically prepared for the company and is not intended for broad public distribution.
This material has been prepared and issued (in Australia) by Henslow Pty Ltd (ABN 38 605 393 137) (AFS Licence No. 483168) (“Henslow”) and is subject to the disclosures and restrictions as set out in the Disclaimer on the last page of the report. Consistent with the AFSL under which Henslow operates, this material has been prepared for “Sophisticated” or “Wholesale” Investors as defined in the Corporations Act 2001 (Cth) (“Corporations Act”). This material is not to be provided to, and is not made available to, Retail Investors. All references to currency or $ are in Australian dollars unless otherwise noted.
1. To confirm you are a Sophisticated or Wholesale Investor, do you attest to having:
- A gross income of $250,000 or more per annum in each of the previous two years; or
- Net assets of at least $2.5 million?
Or
2. To confirm you are a Professional Investor, do you attest to being one of the following:
- A financial services licensee acting as principal
- A body regulated by APRA other than a trustee of a regular superannuation fund, an approved deposit fund, a pooled superannuation trust, or a public sector superannuation scheme within the meaning of the Superannuation Industry (Supervision) Act 1993
- A body registered under the Financial Corporations Act 1974
- A trustee of a superannuation fund, an approved deposit fund, a pooled superannuation trust, or a public sector superannuation scheme within the meaning of the Superannuation Industry (Supervision) Act 1993 and the fund has assets of at least $10 million
- A person that controls at least $10 million (including any assets held by an associate or under a trust that the persons manages)
- A foreign entity that, if established or incorporated in Australia, would be covered by one of the proceeding paragraphs
By clicking below, you confirm that you meet one of the requirements outlined above. Please read our detailed Disclaimer on the last page of the report.
Please fill out your details below:
Alcidion Group Limited (ASX:ALC)
Please refer below to the catalogue of research prepared by Henslow.
Note the below research is for WHOLESALE AND PROFESSIONAL INVESTORS ONLY.
Please refer to the Disclaimer at the back of each report.
Filter:
- All
- Healthcare
-
3Q24 4C & Quarterly
18.04.2024 -
1H24 Results Note
28.02.2024 -
1H24 Results
28.02.2024 -
2Q24 4C & Quarterly Update
31.01.2024 -
Material Contract Extension
11.12.2023 -
1Q24 Quarterly Update | 4C & Capital Raising
01.11.2023 -
FY23 Results
24.08.2023 -
FY23 Results Note
24.08.2023 -
4Q23 4C & Quarterly Report
27.07.2023 -
Silverlink Key Contract Renewal
30.05.2023 -
3Q23 4C & Quarterly Report
27.04.2023 -
1H23 Result Note
25.02.2023 -
1H23 Result
24.02.2023 -
2Q23 4C and Quarterly Update
30.01.2023 -
ADF Contract Extension and Upsize
19.12.2022 -
EPR Contract Win
01.12.2022 -
1Q23 Quarterly Activity & 4C
31.10.2022 -
FY22 Results
30.08.2022 -
FY22 Results
30.08.2022 -
4Q22
27.07.2022 -
3Q22 4C
27.04.2022 -
Contract Upgrade Flash
19.04.2022 -
Contract Upgrade Flash
06.04.2022 -
Contract Upgrade Flash
01.04.2022 -
Contract Win Flash
22.03.2022 -
NHS Tayside Contract Win
16.03.2022 -
Synopsis
01.03.2022 -
1H22 Results Note
23.02.2022 -
1H22 Results Flash
23.02.2022 -
2Q22 4C
27.01.2022 -
SilverLink Acquisition + ADF Contract
09.12.2021 -
1Q22 4C
26.10.2021 -
Contract Wins Note
18.10.2021 -
FY21 Results
25.08.2021 -
4Q21 4C
27.07.2021 -
3Q21 4C
28.04.2021 -
ExtraMed Acquisition
15.04.2021 -
1H21 Results
04.03.2021 -
Initiation
07.10.2020
Looking for investment opportunities?
Backed and vetted by Henslow, unlock a selection of unique investment opportunities. Register an account to get started.
Investment hub